Eliminating hepatitis C virus among people who inject drugs in Baltimore
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs
This study is looking at how well new treatments for hepatitis C work for people in Baltimore who inject drugs and also have HIV, to help find out who might not be getting the care they need and how we can improve their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10543537 on NIH RePORTER |
What this research studies
This research focuses on the elimination of hepatitis C virus (HCV) among people who inject drugs (PWID) in Baltimore, particularly those who are co-infected with HIV. It aims to evaluate the effectiveness of recent HCV treatments and assess the changes in HCV infection rates and liver disease outcomes over time. By studying a community-based cohort, the research will identify which subpopulations are being left behind in treatment efforts and how new infections and reinfections are affecting overall health. The project utilizes a combination of epidemiological methods and community engagement to gather data and inform strategies for HCV elimination.
Who could benefit from this research
Good fit: Ideal candidates for this research include people who inject drugs in Baltimore, especially those who are co-infected with HIV.
Not a fit: Patients who do not inject drugs or are not at risk for hepatitis C may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of hepatitis C and improve liver health outcomes for individuals at risk.
How similar studies have performed: Previous research has shown success in similar approaches to HCV treatment and elimination, indicating a promising potential for this project.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Thomas, David L — Johns Hopkins University
- Study coordinator: Thomas, David L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.